Who
Robert J. Flanagan
Director
Company insider
Files Form 4 as: Director, W. P. Carey Inc. REIT; Director, Sagent Pharmaceuticals; Director, Martek Biosciences; Director, Castle Brands.
In numbers
- Trades disclosed
- 121
- Buys
- 8
- Sells
- 23
- Bought
- $1.4M
- Sold
- $14.7M
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 16 Mar 2006
- Last trade
- 1 Jul 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 2 Jul 2026 | WPC W. P. Carey Inc. REITREITs | SEC FORM 4 Code A | —2,824 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | WPC W. P. Carey Inc. REITREITs | SEC FORM 4 Code A | —2,824 at $0.00 | filing |
| 1 Jul 2025filed 2 Jul 2025 | WPC W. P. Carey Inc. REITREITs | SEC FORM 4 Code A | —2,778 at $0.00 | filing |
| 1 Jul 2024filed 1 Jul 2024 | WPC W. P. Carey Inc. REITREITs | SEC FORM 4 Code A | —3,203 at $0.00 | filing |
| 3 Jul 2023filed 5 Jul 2023 | WPC W. P. Carey Inc. REITREITs | SEC FORM 4 Code A | —2,553 at $0.00 | filing |
| 1 Jul 2022filed 6 Jul 2022 | WPC W. P. Carey Inc. REITREITs | SEC FORM 4 Code A | —1,919 at $0.00 | filing |
| 1 Jul 2021filed 6 Jul 2021 | WPC W. P. Carey Inc. REITREITs | SEC FORM 4 Code A | —2,141 at $0.00 | filing |
| 1 Jul 2020filed 6 Jul 2020 | WPC W. P. Carey Inc. REITREITs | SEC FORM 4 Code A | —2,180 at $0.00 | filing |
| 3 Mar 2020filed 5 Mar 2020 | WPC W. P. Carey Inc. REITREITs | SEC FORM 4 Bought | $82K1,000 at $82.29 | filing |
| 1 Jul 2019filed 2 Jul 2019 | WPC W. P. Carey Inc. REITREITs | SEC FORM 4 Code A | —1,867 at $0.00 | filing |
| 2 Jul 2018filed 3 Jul 2018 | WPC W. P. Carey Inc. REITREITs | SEC FORM 4 Code A | —1,523 at $0.00 | filing |
| 2 Apr 2018filed 3 Apr 2018 | WPC W. P. Carey Inc. REITREITs | SEC FORM 4 Code A | —327 at $0.00 | filing |
| 29 Aug 2016filed 31 Aug 2016 | Sagent Pharmaceuticals | SEC FORM 4 Code U | $175K8,050 at $21.75 | filing |
| 29 Aug 2016filed 31 Aug 2016 | Sagent Pharmaceuticals | SEC FORM 4 Code U | $44K2,000 at $21.75 | filing |
| 29 Aug 2016filed 31 Aug 2016 | Sagent Pharmaceuticals | SEC FORM 4 Code U | $9.4M433,770 at $21.75 | filing |
| 29 Aug 2016filed 31 Aug 2016 | Sagent Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | $186K8,556 at $21.75 | filing |
| 29 Aug 2016filed 31 Aug 2016 | Sagent Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | $15K691 at $21.75 | filing |
| 29 Aug 2016filed 31 Aug 2016 | Sagent Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | $30K1,381 at $21.75 | filing |
| 29 Aug 2016filed 31 Aug 2016 | Sagent Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | $40K1,860 at $21.75 | filing |
| 29 Aug 2016filed 31 Aug 2016 | Sagent Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | $17K760 at $21.75 | filing |
News
No headline names them, or the companies they trade most, lately.